Clinical Type 2 Diabetes Review: Intensification Beyond First-lineTherapy – Royal College of General Practitioners
EU
$0
free
Endocrinology
0.25 Credits
Course Description
Course Details
Expiry Date: 2020-05-27
Faculty
Peter J. Lin (MD, CCFP), Filip K. Knop (MD, PhD), David C.W. Lau (MD, PhD, FRCPC), Thomas Round (MBBS, BSc, DRCOG, MRCGP), David Strain (MBChB, MD, FRCP), Elizabeth Rosolowsky (MD, MPH, FAAP, FRCPC), Robyn L. Houlden (MD, FRCPC), John Axler (MD, CCFP, FCF
Accreditation
Learning Objective(s)
Upon completion of this program, participants will be able to:
- Review the key considerations for selecting an antihyperglycemic agent after metformin therapy
- Examine the impact of cardiovascular disease and patient preference on antihyperglycemic agent selection